BAGELLA, Luigi Marco
 Distribuzione geografica
Continente #
NA - Nord America 4.265
AS - Asia 2.504
SA - Sud America 1.412
EU - Europa 1.358
AF - Africa 102
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 9.658
Nazione #
US - Stati Uniti d'America 4.156
BR - Brasile 1.229
SG - Singapore 1.002
CN - Cina 711
UA - Ucraina 417
DE - Germania 225
VN - Vietnam 221
HK - Hong Kong 197
IT - Italia 143
SE - Svezia 128
FR - Francia 91
GB - Regno Unito 89
FI - Finlandia 86
AR - Argentina 70
IN - India 53
CA - Canada 50
TR - Turchia 47
IQ - Iraq 42
MX - Messico 35
RU - Federazione Russa 35
BD - Bangladesh 31
JP - Giappone 31
EC - Ecuador 28
PL - Polonia 28
ZA - Sudafrica 26
MA - Marocco 24
ES - Italia 23
UZ - Uzbekistan 23
VE - Venezuela 23
PK - Pakistan 18
BE - Belgio 16
KR - Corea 16
CO - Colombia 15
JO - Giordania 13
KE - Kenya 12
LT - Lituania 12
NL - Olanda 12
PY - Paraguay 12
AT - Austria 11
IR - Iran 11
PE - Perù 11
CL - Cile 10
CZ - Repubblica Ceca 10
SA - Arabia Saudita 9
AU - Australia 8
EG - Egitto 8
TN - Tunisia 8
RO - Romania 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BO - Bolivia 6
EU - Europa 6
KG - Kirghizistan 6
NP - Nepal 6
CI - Costa d'Avorio 5
GE - Georgia 5
ID - Indonesia 5
JM - Giamaica 5
KH - Cambogia 5
MY - Malesia 5
PH - Filippine 5
AZ - Azerbaigian 4
DZ - Algeria 4
IL - Israele 4
PA - Panama 4
BH - Bahrain 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
PT - Portogallo 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
GA - Gabon 1
GY - Guiana 1
Totale 9.644
Città #
Dallas 1.140
Chandler 556
Singapore 525
San Jose 303
Jacksonville 246
Ashburn 236
Hong Kong 195
New York 191
Beijing 155
Princeton 152
Nanjing 107
São Paulo 89
Dearborn 79
Ho Chi Minh City 78
Lauterbourg 68
Los Angeles 67
Wilmington 56
Sassari 54
Shanghai 50
Ann Arbor 49
Rio de Janeiro 48
Nanchang 47
Hanoi 46
Boardman 35
Munich 32
Tokyo 31
Woodbridge 29
Santa Clara 28
Warsaw 27
Tianjin 25
Council Bluffs 24
Brasília 23
Shenyang 23
Belo Horizonte 22
Tashkent 22
Baghdad 21
Orem 21
Frankfurt am Main 20
Nuremberg 20
Toronto 20
Hebei 19
Brooklyn 18
Helsinki 18
Campinas 17
Chennai 17
Curitiba 17
Houston 16
Seoul 16
Brussels 15
Denver 15
San Francisco 15
Atlanta 14
Changsha 14
Izmir 14
Ribeirão Preto 14
Amman 13
Biên Hòa 13
Buffalo 13
Guayaquil 13
Johannesburg 13
Montreal 13
Norwalk 13
Poplar 13
Porto Alegre 13
San Mateo 13
Stockholm 13
Augusta 12
Cagliari 12
São Bernardo do Campo 12
Andover 11
Boston 11
Chicago 11
Columbus 11
London 11
Mountain View 11
Nairobi 11
Ningbo 11
The Dalles 11
Da Nang 10
Guarulhos 10
Leawood 10
Osasco 10
Contagem 9
Guangzhou 9
Jinan 9
Lima 9
Manaus 9
Manchester 9
Anápolis 8
Ardabil 8
Fortaleza 8
Monmouth Junction 8
Phoenix 8
Salvador 8
São José dos Campos 8
Turku 8
Amsterdam 7
Barbianello 7
Bragança Paulista 7
Istanbul 7
Totale 5.663
Nome #
Amniotic fluid stem cells morph into a cardiovascular lineage: analysis of a chemically induced cardiac and vascular commitment 235
Antiproliferative and proapoptotic effects of Inula viscosa extract on Burkitt lymphoma cell line. 220
Dysregulation of miRNAs in Soft Tissue Sarcomas 196
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) 196
Anti-senescence efficacy of radio-electric asymmetric conveyer technology 190
Activation and function of murine Cyclin T2A and Cyclin T2B during skeletal muscle differentiation. 189
Evaluation of EZH2 expression in hepatitis B patients 170
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 167
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 163
Sputum analysis: non-invasive early lung cancer detection 161
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines 156
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 151
A promyelocytic leukemia protein-thrombospondin-2 axis and the risk of relapse in neuroblastoma 148
Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements 147
Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis 146
Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy 143
Activation of MyoD-dependent transcription by cdk9/cyclin T2 141
Cloning of murine CDK9/PITALRE and its tissue-specific expression in development 140
Biological characterization of two novel chathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities 139
cDNA sequences of three sheep myeloid cathelicidins 137
Activation and function of cyclin T/Cdk9 (positive transcription elongation factor-b) in cardiac muscle cell hypertrophy 137
Biological Activity of a Novel, Cathelicidin-derived Antimicrobial Peptide from Sheep 137
Chemical synthesis structural features and biological activity of novel mammalian antibiotic peptides identified throw amplification of homologous cDNA sequences 137
A unique domain of pRb2/p130 acts as an inhibitor of cdk2 kinase activity 136
Tet1 and Tdg suppress intestinal tumorigenesis by downregulating the inflammatory and immune responses in the Apc(Min)mouse model 134
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment 132
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 129
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma 127
Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1 126
12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells 125
EZH2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A 123
Frequent loss of pRb2/p130 in human ovarian carcinoma 123
Frequent loss of Rb2/p130 in human ovarian carcinoma 121
Physical interaction between pRb and cdk9/cyclinT2 complex 120
Long noncoding RNA SYISL: the crucial interaction with EZH2 in skeletal muscle differentiation and disorders 120
A new parameter of growth inhibition for cell proliferation assays 120
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 120
Hyaluronan esters drive Smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 115
TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype 113
CTCF and BORIS Regulate Rb2/p130 Gene Transcription: A Novel Mechanism and a New Paradigm for Understanding the Biology of Lung Cancer 113
Molecular cloning, expression and developmental characterization of the murine Retinoblastoma-related gene Rb2/p130 112
Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors 111
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 111
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines 110
Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300 110
A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity and cell cycle arrest 110
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 109
pRb2/p130 has an anti-apoptotic effect on apoptosis triggered by camptothecin and doxorubicin, and not by taxol 108
SFK Inhibitors as New Strategy for RMS Treatment 108
Cyclin E and Chromosome Instability (CIN) in colorectal cancer cell lines 108
MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions 105
“The Retinoblastoma Family Protein p130 as a Negative Regulator of Cell Growth and Tumor Progression” 104
Cdk9-55: a new player in muscle regeneration 104
Viral infections as a cause of cancer 101
Independent prognostic role of p16 expression in lung cancer 99
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment 98
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. 97
Study of viral integration of HPV-16 in young patients with LSIL 96
Tomentosin a Sesquiterpene Lactone Induces Antiproliferative and Proapoptotic Effects in Human Burkitt Lymphoma by Deregulation of Anti- and Pro-Apoptotic Genes 96
Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle 95
PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis 95
Phisical Interacton between cdk9 and B-Myb results in suppression of B-Myb gene autoregulation 94
From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway 93
The BRG1 ATPase of chromatin remodelling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways 92
Role of Enhancer of Zeste Homolog 2 Polycomb Protein and Its Significance in Tumor Progression and Cell Differentiation 90
Roles of enhancer of zeste homolog 2: From skeletal muscle differentiation to rhadbomyosarcoma carcinogenesis. 88
The Retinoblastoma gene family pRb/p105, p107, pRb2/p130 and Simian Virus-40 Large-T antigen in human mesotheliomas 88
Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy 88
Preliminary study in early lung cancer detection using sputum sample 87
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 86
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 85
Nutraceuticals in Pregnancy: A Special Focus on Probiotics 84
Genomic Organization, Promoter Analysis, and Chromosomal Mapping of the Mouse Gene Encoding Cdk9 82
Roscovitine (Seliciclib, cyc202) prevents Cyclin A1 DNA damage induced up-regulation and reduces Double Strand Break (DSB) repair through NHEJ impairment. 77
The COOH-terminal Region of pRb2/p130 Binds to Histone Deacetilase 1 (HDAC1), Enhancing Transcriptional Repression of the E2F-dependent Cyclin A Promoter 77
Role of enhancer of zeste homolog 2 polycomb protein and its significance in tumor progression and cell differentiation 70
Cytometry and DNA Ploidy: Clinical Uses and Molecular Perspective in Gastric and Lung Cancer 69
Interaction Between the Cdk2/Cyclin A Complex and a Small Molecule Derived from the pRb2/p130 Spacer Domain: A Theoretical Model 64
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors 59
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors 57
Silver nanoparticles derived by artemisia arborescens reveal anticancer and apoptosis-inducing effects 50
BET-inhibitor I-BET762 and PARP-inhibitor talazoparib synergy in small cell lung cancer cells 48
null 47
null 36
Essential oils by name and by nature: a review of their antioxidant and neuroprotective potential in Parkinson’s Disease 26
Artemisia silver nanoparticles: green synthesis and antitumoral activity 2
Totale 9.769
Categoria #
all - tutte 38.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021168 0 0 0 0 0 0 0 0 0 78 78 12
2021/2022382 46 2 2 8 2 7 13 35 29 34 38 166
2022/2023980 80 91 18 172 87 165 3 123 168 6 52 15
2023/2024387 46 14 14 5 44 155 9 22 0 6 49 23
2024/20252.598 24 23 136 52 65 95 225 475 854 443 118 88
2025/20263.830 258 956 484 598 404 253 523 109 127 118 0 0
Totale 9.769